60 Degrees Pharmaceuticals, Inc. (SXTP)
60 Degrees Pharmaceuticals will go public soon. The estimated IPO date is June 1, 2023.
IPO Price Range
$4.30 - $6.30
Shares Offered
1,415,095
Deal Size
$7.50M
Company Description
60 Degrees Pharmaceuticals is a growth-oriented specialty pharmaceutical company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
We have successfully achieved regulatory approval of Arakoda, a malaria preventative treatment that has been on the market since late 2019.
Currently, 60P’s pipeline under development covers development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.
60 Degrees Pharmaceuticals, Inc.
| Country | United States |
| Founded | 2010 |
| IPO Date | Jun 1, 2023 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Geoffrey S. Dow |
Contact Details
Address:
1025 Connecticut Avenue NW Suite 1000 Washington, DC, 20036 United States | |
| Phone | (202) 327-5422 |
| Website | 60degreespharma.com |
Stock Details
| Ticker Symbol | SXTP |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001946563 |
| Employer ID | 45-2406880 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Geoffrey Dow | Chief Executive Officer, President and Director |
| Tyrone Miller | Treasurer |
| Bryan Smith | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 24, 2023 | D | Notice of Exempt Offering of Securities |
| May 19, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 28, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Apr 3, 2023 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jan 31, 2023 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Dec 23, 2022 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 5, 2022 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Oct 18, 2022 | DRS | [Cover] Draft Registration Statement |